目的 分析舒泌通胶囊联合氨苄西林治疗泌尿系统感染的临床效果。方法 选择2016年11月—2018年12月在上海市静安区中心医院治疗的泌尿系统感染患者123例，随机分成对照组（61例）和治疗组（62例）。对照组患者口服氨苄西林胶囊，3粒/次，3次/d。治疗组在对照组治疗的基础上饭后口服舒泌通胶囊，4粒/次，3次/d。两组患者均治疗2周。观察两组患者临床疗效，同时比较治疗前后两组患者尿细菌培养、尿白细胞镜检、尿常规恢复时间、临床症状消失时间和尿路刺激征次数。结果 治疗后，对照组和治疗组临床有效率分别为70.49%和90.32%，两组比较差异具有统计学意义（P<0.05）。治疗后，两组患者尿细菌培养、尿白细胞镜检指标均显著降低（P<0.05），且治疗组明显低于对照组（P<0.05）。治疗后，治疗组尿常规恢复时间、临床症状消失时间和尿路刺激征次数明显低于对照组（P<0.05）。结论 舒泌通胶囊联合氨苄西林治疗泌尿系统感染，可明显降低尿细菌培养菌落数和尿白细胞数目，改善患者临床症状，减少尿路刺激征次数，具有一定的临床推广应用价值。

Objective To analyze the clinical effect of Shumitong Capsules combined with ampicillin in treatment of urinary system infection. Methods Patients (123 cases) with urinary system infection in Jing'an District Central Hospital from November 2016 to December 2018 were randomly divided into control (61 cases) and treatment (62 cases) groups. Patients in the control group were po administered with Ampicillin Capsules, 3 grains/time, three times daily. Patients in the treatment group were po administered with Shumitong Capsules on the basis of the control group, 4 grains/time, three times daily. Patients in two groups were treated for 2 weeks. After treatment, the clinical efficacy was evaluated, and the urine bacterial culture, microscopic examination of urinary leucocytes, the time of urine routine recovery and clinical symptom disappearance, and frequency of urinary tract irritation in two groups before and after treatment were compared. Results After treatment, the clinical efficacy and in the control and treatment groups was 70.49% and 90.32% respectively, and there were differences between two groups (P<0.05). After treatment, the urine bacterial culture, microscopic examination of urinary leucocytes in two groups were significantly decreased (P<0.05), and which in the treatment group were significantly lower than that in the control group (P<0.05). After treatment, the time of urine routine recovery and clinical symptom disappearance, and frequency of urinary tract irritation in the treatment group were significantly lower than those in the control group (P<0.05). Conclusion Shumitong Capsules combined with ampicillin in treatment of urinary system infection can significantly reduce the number of cultured bacterial colonies and leukocytes in urine, improve the clinical symptoms and reduce the number of urinary tract irritation signs, which has a certain clinical application value.

R983